✦ LIBER ✦

Pharmacology of E4101, a novel, selective and orally active DA-1 dopamine receptor agonist

✍ Scribed by N. Mori; H. Ishihara; T. Matsuoka; M. Saito; T. Hoshiko; N. Yoneda; S. Suda; M. Yamanaka; M. Shino; S. Hamano

Book ID: 115884740
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 91 KB
Volume: 183
Category: Article
ISSN: 0014-2999
DOI: 10.1016/0014-2999(90)92907-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of a novel, selective dopamine-1

Effect of a novel, selective dopamine-1 agonist, E4101, on renal function in anesthetized dogs

✍ T. Matsuoka; H. Ishihara; T. Hoshiko; N. Yoneda; M. Shino; N. Mori; S. Hamano 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Pharmacological and Pharmacokinetic Char

Pharmacological and Pharmacokinetic Characteristics of YM435, a Novel Dopamine DA1-Receptor Agonist, in Anaesthetized Dogs

✍ TAKEYUKI YATSU; IKUO MIYAMOTO; FUMIYO KANEKO-TAKANUKI; TAKASHI WATANABE; TOICHI 📂 Article 📅 1997 🏛 Pharmaceutical Press 🌐 English ⚖ 483 KB

Receptor profile of KW-3635: a potent, s

Receptor profile of KW-3635: a potent, selective and orally active thromboxane A2 receptor agonist

✍ A. Ishii; I. Miki; E. Ohshima; H. Obase 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Pyridobenzodiazepines: A Novel Class of

Pyridobenzodiazepines: A Novel Class of Orally Active, Vasopressin V2 Receptor Selective Agonists.

✍ Amedeo A. Failli; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 25 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Pharmacological profile of YM348, a nove

Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist

✍ Yasuharu Kimura; Ken-ichi Hatanaka; Yuki Naitou; Kyoichi Maeno; Itsuro Shimada; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 376 KB

Discovery of novel, potent, selective, a

Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core

✍ Dong-Ming Shen; Edward J. Brady; Mari R. Candelore; Qing Dallas-Yang; Victor D.- 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 461 KB

A novel class of 1,3,5-pyrazoles has been discovered as potent human glucagon receptor antagonists. Notably, compound 26 is orally bioavailable in several preclinical species and shows selectivity towards cardiac ion channels, other family B receptors such hGIP and hGLP1, and a large panel of enzyme